Drug Design & Medicinal Chemistry Congress01 - 02 June 2021 | London, UK
Bringing you the latest in enabling technologies, computational based drug design and discovery chemistry. Key focus areas include; DNA encoded libraries, protein-protein interactions, AI/ML in drug design and medicinal chemistry for oncology
The R&D Series includes...
Over 400 attendees representing global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions
A look at the future of drug discovery in new modalities in biotherapeutics, proteins, cell and genetic based discovery.
The latest updates on the integration of screening approaches in phenotypic and genomics based discovery, Organ on the chip and 3D modelling, RNA as novel drug targets
Insights into drug discovery strategies & next generation therapeutics, empowering drug discovery with chemical biology, target validation, drug profiling and protein degradation technologies
Explore successful strategies in compound library development, DNA/RNA encoded library, protein to protein interaction, fragment and structured based drug design
Focus on cutting edge tools, including; AI in ADME, big data management, model management, artificial intelligence, machine learning in drug design and AI in chemical synthesis, AI-enabled target ID capabilities, lead identification/optimisation and much more…
Last Year's Agenda at a Glance
Day One
- Strategies in Computational Drug Design
- Design of Novel Compound Libraries for Synthesis
- Screening- DNA and other Encoded Libraries
- AI in Chemical Synthesis, Target ID Capabilities, Lead Identification, Lead Optimisation, Measuring PK/PD and Prediction
Day Two
- Fragment based Drug Discovery
- Protein to Protein Interactions
- Structure-based Approaches
